Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer.

Respiratory research2025Dai L, Wang X, Lou N, et al.

Study designOther primary literature

SubjectHuman & animal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AgedAmino Acids, Branched-ChainAnimalsBiomarkers, TumorCarcinoma, Non-Small-Cell LungFemaleHumansImmunotherapyLeucineLung NeoplasmsMaleMetabolomicsMiceMiddle AgedMultiomicsPrognosisTreatment Outcome

DOI 10.1186/s12931-025-03277-8

PMID 40457349

View source →